?. Janssen, M. Cilagaustralia-), M. Lipha, &. Sharp, and . Dohme, Novartis Pharmaceutical (Australia), Novo Nordis Pharmaceutical, Pharmacia and Upjohn, Pfizer, Roche Diagnostics, Sanofi Synthelabo (Australia) Servier Laboratories (Australia), Bio-Rad Laboratories, HITECH Pathology, the Australian Kidney Foundation, Diabetes Australia, Diabetes Australia (Northern Territory), Queensland Health, South Australian Department of Human Services, Tasmanian Department of Health and Human Services, Territory Health Services and Victorian Department of Human Services, and Health Department of Western Australia. For their invaluable contribution to the set-up and field activities of

F. Whalen and . Wilson, Finally, we thank the AusDiab participants for volunteering their time to participate in the study

H. Johnsen-(-co-pi-), T. Ibsen, T. Thomsen, K. Jørgensen, C. Borch-johnsen et al., The Inter99 steering committee comprises, The authors thank the staff of Inter99 and all the participants

D. E. The, study has been supported by INSERM contracts with CNAMTS, Lilly, Novartis Pharma and Sanofi-Aventis; by INSERM (Réseaux en Santé Publique, Interactions entre les déterminants de la santé), Cohortes Santé TGIR, the Association Diabète Risque Vasculaire, the Fédération Française de Cardiologie

. Soulimane, HbA1c, FPG predicting diabetes 13, 2012.

C. , R. Bonnet, and L. Cnrs-umr8090, P Froguel; Centres d'Examens de Santé

M. Générale, :. Cogneau, C. Born, . Caces, . Cailleau et al., General practitioners of the region; Institute inter-Regional pour la Santé, J Tichet, S, vol.REFERENCES ___________________________________________________________________

K. Narayan, J. Boyle, L. Geiss, J. Saaddine, and T. Thompson, Impact of Recent Increase in Incidence on Future Diabetes Burden: U.S., 2005-2050, Diabetes Care, vol.29, issue.9, pp.2114-2120, 2005.
DOI : 10.2337/dc06-1136

J. Shaw, R. Sicree, and P. Zimmet, Global estimates of the prevalence of diabetes for 2010 and 2030, Diabetes Research and Clinical Practice, vol.87, issue.1, pp.4-14, 2010.
DOI : 10.1016/j.diabres.2009.10.007

C. Droumaguet, B. Balkau, D. Simon, E. Caces, J. Tichet et al., Use of HbA1c in Predicting Progression to Diabetes in French Men and Women: Data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR), Diabetes Care, vol.29, issue.7
DOI : 10.2337/dc05-2525
URL : https://hal.archives-ouvertes.fr/inserm-00085250

M. Abdul-ghani, V. Lyssenko, T. Tuomi, R. Defronzo, and L. Groop, Fasting Versus Postload Plasma Glucose Concentration and the Risk for Future Type 2 Diabetes: Results from the Botnia Study, Diabetes Care, vol.32, issue.2, pp.281-287, 2009.
DOI : 10.2337/dc08-1264

C. Kim, K. Bullard, W. Herman, and G. Beckles, Association Between Iron Deficiency and A1C Levels Among Adults Without Diabetes in the National Health and Nutrition Examination Survey, 1999-2006, Diabetes Care, vol.33, issue.4, pp.780-785, 1999.
DOI : 10.2337/dc09-0836

K. Borch-johnsen and S. Colagiuri, Diagnosing diabetes--time for a change? Diabetologia, pp.2247-50, 2009.

R. Hanas and G. John, 2010 Consensus statement on the worldwide standardization of the hemoglobin A1c measurement, Diabetes Research and Clinical Practice, vol.90, issue.2, pp.228-258, 2010.
DOI : 10.1016/j.diabres.2010.05.011

. Soulimane, HbA1c, FPG predicting diabetes 14, 2012.

K. Borch-johnsen, S. Colagiuri, B. Balkau, C. Glumer, B. Carstensen et al., Creating a pandemic of prediabetes: the proposed new diagnostic criteria for impaired fasting glycaemia, Diabetologia, vol.47, issue.8, pp.1396-402, 2004.
DOI : 10.1007/s00125-004-1468-6

J. Dekker and B. Balkau, Counterpoint: Impaired Fasting Glucose: The Case Against the New American Diabetes Association Guidelines, Diabetes Care, vol.29, issue.5, pp.1173-1178, 2006.
DOI : 10.2337/dc05-2220

K. Sato, T. Hayashi, N. Harita, T. Yoneda, Y. Nakamura et al., Combined Measurement of Fasting Plasma Glucose and A1C Is Effective for the Prediction of Type 2 Diabetes: The Kansai Healthcare Study, Diabetes Care, vol.32, issue.4, pp.644-650, 2009.
DOI : 10.2337/dc08-1631

H. Cederberg, T. Saukkonen, M. Laakso, J. Jokelainen, P. Härkönen et al., Postchallenge Glucose, A1C, and Fasting Glucose as Predictors of Type 2 Diabetes and Cardiovascular Disease: A 10-year prospective cohort study, Diabetes Care, vol.33, issue.9, pp.2077-83, 2010.
DOI : 10.2337/dc10-0262

C. Glumer, T. Jorgensen, and K. Borch-johnsen, Prevalences of Diabetes and Impaired Glucose Regulation in a Danish Population: The Inter99 study, Diabetes Care, vol.26, issue.8, pp.2335-2375, 2003.
DOI : 10.2337/diacare.26.8.2335

D. Dunstan, P. Zimmet, T. Welborn, A. Cameron, J. Shaw et al., The Australian Diabetes, Obesity and Lifestyle Study (AusDiab)???methods and response rates, Diabetes Research and Clinical Practice, vol.57, issue.2, pp.119-148, 2002.
DOI : 10.1016/S0168-8227(02)00025-6

D. Magliano, E. Barr, P. Zimmet, A. Cameron, D. Dunstan et al., Glucose Indices, Health Behaviors, and Incidence of Diabetes in Australia: The Australian Diabetes, Obesity and Lifestyle Study, Diabetes Care, vol.31, issue.2, pp.267-72, 2008.
DOI : 10.2337/dc07-0912

K. Ulm, A statistical method for assessing a threshold in epidemiological studies, Statistics in Medicine, vol.7, issue.3
DOI : 10.1002/sim.4780100306

D. Edelman, M. Olsen, T. Dudley, A. Harris, and E. Oddone, Utility of hemoglobin A1c in predicting diabetes risk, Journal of General Internal Medicine, vol.136, issue.1, pp.1175-80, 2004.
DOI : 10.1111/j.1525-1497.2004.40178.x

S. Mostafa, K. Khunti, B. Srinivasan, D. Webb, L. Gray et al., The potential impact and optimal cut-points of using glycated haemoglobin, HbA1c, to detect people with impaired glucose regulation in a UK multi-ethnic cohort, Diabetes Research and Clinical Practice, vol.90, issue.1
DOI : 10.1016/j.diabres.2010.06.008

. Soulimane, HbA1c, FPG predicting diabetes 15, 2012.

S. Genuth, K. Alberti, P. Bennett, J. Buse, R. Defronzo et al., Follow-up report on the diagnosis of diabetes mellitus, Diabetes Care, vol.26, pp.3160-3167, 2003.

K. Inoue, M. Matsumoto, and K. Akimoto, as risk factors for Type??2 diabetes, Diabetic Medicine, vol.36, issue.10, pp.1157-63, 2008.
DOI : 10.1111/j.1464-5491.2008.02572.x

J. Saaddine, A. Fagot-campagna, D. Rolka, K. Narayan, L. Geiss et al., Distribution of HbA1c Levels For Children and Young Adults in the U.S.: Third National Health and Nutrition Examination Survey, Diabetes Care, vol.25, issue.8, pp.1326-1356, 2002.
DOI : 10.2337/diacare.25.8.1326

S. Soulimane, D. Simon, J. Shaw, P. Zimmet, S. Vol et al., Comparing incident diabetes as defined by fasting plasma glucose or by HbA1c. The AusDiab, Inter99 and D, E.S.I.R. studies. Diabetic Medicine
URL : https://hal.archives-ouvertes.fr/inserm-00659378

. Soulimane, HbA1c, FPG predicting diabetes 16, 2012.